Sign Up
Stories
Bone Biologics Raises $2.0 Million
Share
BioPharma Shift: Coherus-Sandoz Acquisit...
Biopharma Companies Announce Public Offe...
Biotech Innovations and Financing
AHF Calls for Global Health Equity
Acquisition Progress Amid Safety Concern
Afya Limited Expands Medical Seats in Br...
Overview
API
Bone Biologics completes a $2.0 million public offering to fund clinical trials and corporate needs, with H.C. Wainwright & Co. as the placement agent.
Ask a question
How does the role of placement agents like H.C. Wainwright & Co. influence fundraising outcomes for companies like Bone Biologics?
How might the successful public offering impact Bone Biologics' research and development timeline?
What competitive advantages could the secured funds provide Bone Biologics within the biotechnology sector?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage